Compare BIOA & VINP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIOA | VINP |
|---|---|---|
| Founded | 2015 | 2009 |
| Country | United States | Brazil |
| Employees | 62 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 681.9M | 753.0M |
| IPO Year | N/A | 2020 |
| Metric | BIOA | VINP |
|---|---|---|
| Price | $16.11 | $10.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $51.50 | $14.00 |
| AVG Volume (30 Days) | ★ 354.1K | 85.7K |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 5.72% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $720.93 | $18.07 |
| Revenue Next Year | N/A | $12.74 |
| P/E Ratio | ★ N/A | $24.41 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.79 | $9.20 |
| 52 Week High | $24.00 | $13.61 |
| Indicator | BIOA | VINP |
|---|---|---|
| Relative Strength Index (RSI) | 42.51 | 41.90 |
| Support Level | $15.74 | $9.47 |
| Resistance Level | $19.01 | $10.40 |
| Average True Range (ATR) | 1.31 | 0.45 |
| MACD | -0.16 | -0.08 |
| Stochastic Oscillator | 30.46 | 30.40 |
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
Vinci Compass Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Equity, Equities, Real Assets, Credit, Global IP&S, and Corporate Advisory. The company's majority of its revenue comes from the Private Equity segment, which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.